1. 0005 COMPARISON OF PACLITAXEL, CISPLATIN (TP), VERSUS PACLITAXEL, IFOSFAMIDE, CISPLATIN (TIP), AS NEOADJU-VANT CHEMOTHERAPY TO RADICAL SURGERY IN LOCALLY ADVANCED SQUAMOUS CELL CERVICAL CARCINOMA (LASCCC): THE SNAP-02 ITALIAN STUDY. (1st September 2005) Authors: Colombo, N.; Buda, A.; Parma, G.; Rulli, E.; Lissoni, A.; Floriani, I.; Fei, F.; Zola, P.; Katsaros, D.; Grassi, R.; Mangioni, C. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 0614: Laparoscopic Radical Parametrectomy Including Pelvic Lymphadenectomy in Women with Occult Uterine Cancer After Prior Symple Hysterectomy. (1st October 2006) Authors: Pellegrino, A.; Buda, A.; Vizza, E.; Meroni, M.; Vitobello, D.; Maneo, A.; Lissoni, A.; Battistello, M.; Mangioni, C. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 3 Page Start: 772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Do unresponsive wakefulness syndrome patients feel pain? Role of laser-evoked potential-induced gamma-band oscillations in detecting cortical pain processing. (11th March 2016) Authors: Naro, A.; Leo, A.; Cannavò, A.; Buda, A.; Bramanti, P.; Calabrò, R.S. Journal: Neuroscience Issue: Volume 317(2016) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dynamic thermal and hygrometric simulation of historical buildings: Critical factors and possible solutions. (February 2020) Authors: Akkurt, G.G.; Aste, N.; Borderon, J.; Buda, A.; Calzolari, M.; Chung, D.; Costanzo, V.; Del Pero, C.; Evola, G.; Huerto-Cardenas, H.E.; Leonforte, F.; Lo Faro, A.; Lucchi, E.; Marletta, L.; Nocera, F.; Pracchi, V.; Turhan, C. Journal: Renewable & sustainable energy reviews Issue: Volume 118(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma. Issue 4 (1st June 2015) Authors: Realdon, S.; Dassie, E.; Fassan, M.; Dall'Olmo, L.; Hatem, G.; Buda, A.; Arcidiacono, D.; Diamantis, G.; Zhang, H.; Greene, M. I.; Sturniolo, G. C.; Rugge, M.; Alberti, A.; Battaglia, G. Journal: Diseases of the esophagus Issue: Volume 28:Issue 4(2015) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma. Issue 4 (7th April 2014) Authors: Realdon, S.; Dassie, E.; Fassan, M.; Dall'Olmo, L.; Hatem, G.; Buda, A.; Arcidiacono, D.; Diamantis, G.; Zhang, H.; Greene, M. I.; Sturniolo, G. C.; Rugge, M.; Alberti, A.; Battaglia, G. Journal: Diseases of the esophagus Issue: Volume 28:Issue 4(2015) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.02.5 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART1. Issue 2 (15th March 2018) Authors: Bergamaschi, G.; Giuffrida, P.; Fries, W.; Aronico, N.; D'Incà, R.; Lenti, M.V.; Ciacci, C.; Cococcia, S.; Bossa, F.; Ghigliazza, G.; Castiglione, F.; Principi, M.B.; Ricci, C.; Mazzucco, D.; Milla, M.; Pieraccini, A.; Scribano, M.L.; Riegler, G.; Bodini, G.; Bassotti, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.02.5: Periendoscopic Management of Direct Oral Anticoagulants: A Prospective Cohort Study. (15th March 2017) Authors: Radaelli, F.; Fuccio, L.; Paggi, S.; Di Leo, M.; Trovato, C.; Ottaviano, T.; Buda, A.; Musso, A.; De Bellis, M.; Fasoli, R.; Liverani, E.; Giardini, M.; Hassan, C.; Repici, A.; Dentali, F. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH. (25th March 2019) Authors: Buda, A.; Facchin, S.; Lorenzon, G.; Barberio, B.; Zingone, F.; Savarino, E.; D'Incà, R. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.12.4 RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES AND CLINICAL SCORES IN INFLAMMATORY BOWEL DISEASE PATIENTS. (25th March 2019) Authors: Facchin, S.; Buda, A.; Cardin, R.; Agbariah, N.; Zingone, F.; De Boni, M.; D'Incà, R.; Savarino, E. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗